Summary
Merck & Co., Inc. (MRK) filed an 8-K on July 30, 2013, to report its financial results for the second quarter of 2013. The filing incorporates by reference a press release and supplemental information detailing the company's performance during the quarter. Investors should review these attached exhibits for specific financial figures, operational highlights, and forward-looking statements that were disclosed at the time. This report serves as a crucial update for shareholders, providing insights into Merck's revenue, earnings, and overall financial condition as of the end of the second quarter. While the 8-K itself does not contain the detailed financial tables, it directs investors to the readily available press release and supplemental data, which are essential for a comprehensive understanding of the company's recent performance and strategic positioning.
Key Highlights
- 1Merck filed an 8-K on July 30, 2013, reporting its second quarter 2013 financial results.
- 2The filing incorporates by reference a press release dated July 30, 2013 (Exhibit 99.1).
- 3Supplemental financial information not included in the press release is also attached as Exhibit 99.2.
- 4The 8-K indicates the information is furnished under Item 2.02 (Results of Operations and Financial Condition).
- 5This report provides an official update on Merck's financial performance for the second quarter of 2013.
- 6The information provided is not deemed 'filed' for purposes of Section 18 of the Exchange Act, but is incorporated by reference in future filings as specified.